Valuation: Aprogen Biologics Inc.

Market Cap 22.45B 16.93M 15.22M 14.03M 12.73M 23.77M 1.61B 24.09M 168M 66.92M 843M 63.53M 62.14M 2.68B P/E 2024
-0.79x
P/E 2025 -0.6x
Enterprise Value 200B 151M 135M 125M 113M 211M 14.31B 214M 1.5B 595M 7.5B 565M 553M 23.84B EV / Sales 2024
3.66x
EV / Sales 2025 3.82x
Free-Float
24.16%
Yield 2024 *
-
Yield 2025 -
1 day+0.58%
1 week-7.41%
Current month-5.65%
1 month-15.38%
3 months-33.48%
6 months-63.16%
Current year-82.18%
1 week 1,369
Extreme 1369
1,509
1 month 1,369
Extreme 1369
1,725
Current year 1,369
Extreme 1369
8,490
1 year 1,369
Extreme 1369
9,945
3 years 1,369
Extreme 1369
53,250
5 years 1,369
Extreme 1369
154,500
10 years 1,369
Extreme 1369
858,000
Manager TitleAgeSince
Chief Executive Officer 63 12/10/2023
Chief Executive Officer 70 31/03/2012
Sales & Marketing 62 -
Director TitleAgeSince
Director/Board Member 70 31/03/2012
Director/Board Member 65 22/03/2020
Director/Board Member 63 12/10/2023
Date Insider Type Main position Quantity % Market Cap. Importance
28/06/24 Exercice

Executive/Senior Manager

6,183 0.0046%
28/06/24 Expiration

Chief Executive Officer

21,884 0.0164%
28/06/24 Exercice 11,846 0.0089% -
Change 5-day change 1-year change 3-year change Capi.($)
+0.58%-7.41%-83.55%-97.19% 16.82M
+0.22%+3.35%+55.30%+125.65% 1,140B
+0.91%+5.89%+41.14%+80.36% 641B
-0.12%+1.31%+25.62%+97.24% 507B
+0.63%+4.97%+47.12%+68.18% 383B
+0.86%-1.26%+62.10%+34.36% 347B
+1.02%+3.69%+23.73%+51.35% 293B
-0.25%+3.40%+2.31%+23.38% 266B
+0.75%+5.41%+53.53%+66.09% 240B
+0.25%+3.93%+31.54%+102.65% 197B
Average +0.19%+2.26%+25.88%+55.21% 401.38B
Weighted average by Cap. +0.02%+2.98%+42.01%+84.56%

Financials

2024 2025
Net sales 67.38B 50.8M 45.68M 42.11M 38.2M 71.35M 4.83B 72.3M 506M 201M 2.53B 191M 187M 8.05B 73.23B 55.21M 49.65M 45.77M 41.52M 77.55M 5.25B 78.57M 550M 218M 2.75B 207M 203M 8.74B
Net income -105B -79.15M -71.18M -65.61M -59.52M -111M -7.53B -113M -788M -313M -3.94B -297M -291M -12.54B -170B -128M -115M -106M -96.58M -180M -12.21B -183M -1.28B -508M -6.4B -482M -471M -20.34B
Net Debt 116B 87.24M 78.44M 72.31M 65.6M 123M 8.3B 124M 868M 345M 4.35B 327M 320M 13.82B 177B 134M 120M 111M 100M 188M 12.7B 190M 1.33B 528M 6.66B 501M 490M 21.16B
Projected Income Statement - Annual - Aprogen Biologics Inc.
Logo Aprogen Biologics Inc.
Aprogen Biologics Inc, formerly Aprogen Pharmaceuticals Inc, is a Korea-based company principally engaged in the pharmaceutical business. The Company operates its business through two segments. The Medicine Business segment is engaged in the manufacture and sale of central nervous system drugs, autonomic agents, arteriosclerosis agents, metabolic agents, circulatory system drugs, biopharmaceuticals and others. The Segment is also engaged in the manufacture and sale of cosmetics such as skin moisturizers and others. The Gaming Business segment is engaged in the development and operation of role-playing games (RPGs).
Employees
262
Date Price Change Volume
27/10/26 ₩1,387.00 +0.58% 47,488
26/10/26 ₩1,379.00 -0.58% 98,417
23/10/26 ₩1,387.00 -1.49% 107,052
22/10/26 ₩1,408.00 -2.22% 115,788
21/10/26 ₩1,440.00 -1.50% 84,857
  1. Stock Market
  2. Stocks
  3. A003060 Stock